Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-16

Clinical Trial Update: Melatonin Versus Placebo for Bipolar Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing melatonin versus placebo for Bipolar Affective Disorder, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)

Snippet

Sponsor: Lars Vedel Kessing | Conditions: Bipolar Affective Disorder | Phase 2 | Status: NOT_YET_RECRUITING